IMMUNEERING CORP - CLASS A (IMRX) Stock Income Statement
NASDAQ:IMRX - Nasdaq - US45254E1073 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 320.00K | 2.08M | |||
| Cost Of Goods | N/A | N/A | 0.00 | 160.00K | 1.15M | |||
| Gross Profit | N/A | N/A | 0.00 | 160.00K | 930.00K | |||
| Operating Expenses | 64.00M | 64.00M | 58.00M | 51.90M | 34.82M | |||
| Research and Development | 48.17M | N/A | 41.40M | 36.11M | 26.51M | |||
| Selling, General, and Administrative Expenses | 15.96M | 16.00M | 17.00M | 15.61M | 8.27M | |||
| Operating Income | -64.00M | -64.00M | -58.00M | -51.74M | -33.89M | |||
| Interest Income/Expense | 2.23M | N/A | 3.61M | 1.01M | 170.00K | |||
| Other Income/Expense | 230.00K | 3.00M | 1.33M | 220.00K | -130.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -62.00M | -61.00M | -53.00M | -50.51M | -33.84M | |||
| Income Tax | N/A | N/A | N/A | N/A | -310.00K | |||
| Net Income | -62.00M | -61.00M | -53.00M | -50.51M | -33.54M | |||
| EBITDA | -63.61M | -63.61M | -57.65M | -51.46M | -33.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.96 | -2.04 | -1.88 | -1.91 | -2.46 | |||
| Non GAAP EPS | -1.96 | -2.03 | -1.89 | -1.92 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 50.00% | 44.71% | |||
| Profit Margin | N/A | N/A | N/A | -15784.38% | -1612.50% | |||
| Operating Profit Margin | N/A | N/A | N/A | -16168.75% | -1629.33% | |||
All data in USD